Francisco Robert - Concepedia

Author

Francisco Robert

University of Alabama at Birmingham

Also Known As

F ROBERT, F Robert, F. Robert, Finn Christopher Robert, Francisco Robert, Robert E. Merritt

148

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham The University of Texas MD Anderson Cancer Center Birmingham VA Medical Center Duke Medical Center Sarah Cannon

About

Francisco Robert is an author at University of Alabama at Birmingham specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	39	2K
2	Health Sciences	11	12	512
3	Cell Biology	3	3	48
4	Public Health	1	1	31
5	Anesthesia	1	1	64

Francisco Robert

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, The Lancet Oncology Dll3-targeted Antibody-drug ConjugateMedicineImmunologyImmune Checkpoint InhibitorCancer Treatment	2016	537
Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer Francisco Robert, Mark P. Ezekiel, Sharon A. Spencer, Journal of Clinical Oncology	2001	473
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. James A. Bonner, Kevin P. Raisch, Hoa Q. Trummell, PubMed	2000	220
Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324 George R. Blumenschein, Rebecca Paulus, Walter J. Curran, Journal of Clinical Oncology	2011	163
Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer Michael Fanucchi, Frank V. Fossella, Robert J. Belt, Journal of Clinical Oncology	2006	155
Phase I/IIa Study of Cetuximab With Gemcitabine Plus Carboplatin in Patients With Chemotherapy-Naïve Advanced Non–Small-Cell Lung Cancer Francisco Robert, George Blumenschein, Roy S. Herbst, Journal of Clinical Oncology	2005	151
Women With Pathologic Stage I, II, and III Non-small Cell Lung Cancer Have Better Survival Than Men Robert J. Cerfolio, Ayesha S. Bryant, E. W. Scott, CHEST Journal MedicineCancer ManagementPathologyBronchial NeoplasmOncology	2006	150
Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer Chandra P. Belani, J. S. Lee, Mark A. Socinski, Annals of Oncology OncologyMedicineMetronomic TherapyPhase Iii TrialBronchial Neoplasm	2005	147
Non-Small Cell Lung Cancer Guidelines David S. Ettinger, Gerold Bepler, Raphael Bueno, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementPathologyTumor BiologyLung Cancer Cases	2006	138
Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022 Joseph O. Moore, Richard K. Dodge, Philip C. Amrein, Blood	1997	110

Page 1